Search clinical trials for: Secretory Leukocyte Peptidase Inhibitor
Total 1172 results
-
University of FlorenceAzienda Ospedaliero-Universitaria Careggi; Istituto per lo Studio, la Prevenzione...Recruiting
-
National Institute of Dental and Craniofacial Research...Completed
-
Mayo ClinicPatient-Centered Outcomes Research InstituteActive, not recruitingType 2 Diabetes | Cardiac DiseaseUnited States
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | NASHEgypt
-
Attikon HospitalRecruiting
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Bulgaria, Czechia, Hungary, Poland, Russian Federation
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States
-
Changhua Christian HospitalCompletedType 2 Diabetes Mellitus | Proteinuria
-
Ajou University School of MedicineDong-A ST Co., Ltd.Not yet recruitingCerebral Infarction | Dipeptidyl-Peptidase IV Inhibitors | Infarction, Brain
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknown
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknownLiver TransplantationDenmark
-
Vanderbilt UniversityCompletedHypertension | Diabetes Type 2United States
-
Panineeya Mahavidyalaya Institute of Dental Sciences...CompletedPulmonary Disease, Chronic Obstructive | Generalized Chronic PeriodontitisIndia
-
Ain Shams UniversityCompleted
-
University of British ColumbiaTerminated
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of British ColumbiaMerck Frosst Canada Ltd.Completed
-
The Catholic University of KoreaCompletedDiabetes MellitusKorea, Republic of
-
PfizerNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Stanley Dudrick's Memorial HospitalTerminated
-
Maastricht University Medical CenterUnilever R&DCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Boehringer IngelheimCompleted
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Janssen Research & Development, LLCCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
TakedaCompleted
-
Beni-Suef UniversityFaculty of Medicine, Minia University; Clinical Pharmacy Department, Faculty...Not yet recruiting
-
Peking University People's HospitalPeking University First Hospital; Jiangsu Province Geriatric InstituteRecruitingDiabetes Mellitus, Type 2 | Severe Insulin Deficient DiabetesChina
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Mexico, United States, Estonia, Bulgaria, Latvia, Romania, Lithuania, Puerto Rico, Costa Rica
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Italy, United States, Germany, Canada, Puerto Rico
-
Brigham and Women's HospitalCompleted
-
University of PadovaCompletedType 2 DiabetesItaly
-
Federal University of São PauloNovartisUnknownType 1 Diabetes | Autoimmune Diabetes | Insulin Dependent Diabetes | Juvenile Onset Diabetes MellitusBrazil
-
Genentech, Inc.CompletedRenal Cell Carcinoma | MetastasesUnited States
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
University College DublinEli Lilly and Company; Merck Sharp & Dohme LLC; Royal College of Physicians; Irish...CompletedDiabetic Nephropathy | Type 2 DiabetesIreland
-
Weill Medical College of Cornell UniversityPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
Effexus PharmaceuticalSouthern Arizona VA Health Care SystemUnknownHeartburn | Gastroesophageal Reflux Disease (GERD) | IndigestionUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Nanjing First Hospital, Nanjing Medical University; Wuxi People's Hospital; Changzhou... and other collaboratorsRecruitingType 2 Diabetes Mellitus | Mild Cognitive ImpairmentChina
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
University of Sao Paulo General HospitalUniversity of Sao PauloCompletedDiabetes Type 2Brazil
-
Royal Devon and Exeter NHS Foundation TrustNIHR Exeter Clinical Research FacilityCompleted
-
Paul SzabolcsRecruitingSickle Cell Anemia | Diamond-blackfan Anemia | Beta-thalassemia MajorUnited States
-
PT. Prodia Stem Cell IndonesiaRecruiting
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedDiabetes Mellitus, Type 2 | Diabetic Ketoacidosis | Lower Extremity Amputation | UrosepsisCanada
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States